Neurological and psychiatric conditions like epilepsy, Parkinson's, and depression are rising fast across India, driving strong demand for anti-epileptic, antidepressant, neuropathic pain, and cognitive health medicines — and that's exactly why a neuro PCD pharma franchise is becoming one of the most focused, repeat-business opportunities in Indian pharma today. In this first episode of Mind & Medicine, we look at why the neuro segment behaves differently from a general-range PCD franchise, why deep specialization builds stronger doctor relationships than a broad product list, and how companies like Holy Evolution Pharma have built a monopoly-based franchise model specifically around CNS and neuropsychiatry care. For more on Holy Evolution Pharma's neuro PCD franchise and product range, visit holyevolutionpharma.co.
続きを読む
一部表示